In recent years, hyperspectral imaging (HSI) has demonstrated its capacity to non-invasively differentiate tumors from healthy tissues and identify cancerous regions during neurosurgery. Indeed, the spectral information contained in the HS images allows to identify more chromophores, refining the information provided by the imaging system, and allowing to identify the unique signature of each tissue types more accurately. Our HyperProbe project aims at developing a novel HSI system optimized for neurosurgery. As part of this project, we are developing a digital instrument simulator (DIS), based on Monte-Carlo (MC) simulations of the light propagation in tissues, in order to optimize both the hardware and data processing pipeline of our novel instrument. This framework allows us (1) to test the effect on the accuracy of the measurement of several hardware parameters, like the numerical aperture or sensitivity of the detector; (2) to be used as numerical phantoms to test various data processing algorithms; and (3) to generate generic data to develop and train machine learning (ML) algorithms. To do so, our framework is based on a 2-step method. Firstly, MC simulations are run to produce an ideal dataset of the photon transport in tissue. Then, the raw output parameters of the simulations, such as the exit positions and directions of the photons, are processed to take into account the physical parameters of an instrument in order to produce realistic images and test various scenarios. We present here the initial development of this DIS.
Recent advancements in imaging technologies (MRI, PET, CT, among others) have significantly improved clinical localisation of lesions of the central nervous system (CNS) before surgery, making possible for neurosurgeons to plan and navigate away from functional brain locations when removing tumours, such as gliomas. However, neuronavigation in the surgical management of brain tumours remains a significant challenge, due to the inability to maintain accurate spatial information of pathological and healthy locations intraoperatively. To answer this challenge, the HyperProbe consortium have been put together, consisting of a team of engineers, physicists, data scientists and neurosurgeons, to develop an innovative, all-optical, intraoperative imaging system based on (i) hyperspectral imaging (HSI) for rapid, multiwavelength spectral acquisition, and (ii) artificial intelligence (AI) for image reconstruction, morpho-chemical characterisation and molecular fingerprint recognition. Our HyperProbe system will (1) map, monitor and quantify biomolecules of interest in cerebral physiology; (2) be handheld, cost-effective and user-friendly; (3) apply AI-based methods for the reconstruction of the hyperspectral images, the analysis of the spatio-spectral data and the development and quantification of novel biomarkers for identification of glioma and differentiation from functional brain tissue. HyperProbe will be validated and optimised with studies in optical phantoms, in vivo against gold standard modalities in neuronavigational imaging, and finally we will provide proof of principle of its performances during routine brain tumour surgery on patients. HyperProbe aims at providing functional and structural information on biomarkers of interest that is currently missing during neuro-oncological interventions.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.